We have received questions regarding Evusheld as a pre-exposure preventative treatment for COVID-19. Evusheld is given as two intramuscular injections. This is only being supplied and administered at select clinic sites such as cancer and transplant centers due to the limited criteria for its use.
Evusheld is currently available in Ontario only to select immunocompromised patients, including:
• Solid organ transplant recipients
• Stem cell transplant recipients
• CAR-T cell therapy recipients
• Other hematologic cancer patients undergoing treatment
Currently, this means that patients receiving advanced therapies for autoimmune conditions are not included in the eligible list.
Please see the Government of Ontario document here for more information.
Carolyn Whiskin is the Pharmacy Manager for Charlton Health. Carolyn specializes in the treatment of autoimmune diseases, pharmaceutical compounding, women’s health, pain, and smoking cessation. Carolyn has won provincial and national awards for her commitment to patient care and public service.
Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition that can be very painful and…
As the year comes to a close, we wish you a joyful holiday season filled…
Pulmonary arterial hypertension occurs when there is increased pressure in the small blood vessels that…
Polymyalgia rheumatica (PMR) is an inflammatory condition that causes widespread joint and muscle pain along…
Respiratory Syncytial Virus (RSV) is a common virus that can cause serious lung infections, particularly in…
Health Canada has recently approved Rinvoq (upadacitinib) for adults living with Giant Cell Arteritis (GCA). Rinvoq…